DNM1L and myocardial infarction: Mdivi-1 increased mitochondrial complex I/II/III/IV activities and ATP content in I/R myocardium (P < 0.05 or P < 0.01, Fig. 3), indicating that Drp1 inhibition improved mitochondrial function in diabetic MI/R hearts.